Cargando…

Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton

Senescence drives organismal aging, yet the deep characterization of senescent cells in vivo remains incomplete. Here, we apply mass cytometry by time-of-flight using carefully validated antibodies to analyze senescent cells at single-cell resolution. We use multiple criteria to identify senescent m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doolittle, Madison L., Saul, Dominik, Kaur, Japneet, Rowsey, Jennifer L., Vos, Stephanie J., Pavelko, Kevin D., Farr, Joshua N., Monroe, David G., Khosla, Sundeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390564/ https://www.ncbi.nlm.nih.gov/pubmed/37524694 http://dx.doi.org/10.1038/s41467-023-40393-9

Ejemplares similares

Multiparametric senescent cell phenotyping reveals CD24 osteolineage cells as targets of senolytic therapy in the aged murine skeleton
por: Doolittle, Madison L., et al.
Publicado: (2023)

Identification of a suitable endogenous control miRNA in bone aging and senescence
por: Kaur, Japneet, et al.
Publicado: (2022)

MicroRNA‐19a‐3p Decreases with Age in Mice and Humans and Inhibits Osteoblast Senescence
por: Kaur, Japneet, et al.
Publicado: (2023)

Modulation of fracture healing by the transient accumulation of senescent cells
por: Saul, Dominik, et al.
Publicado: (2021)

Cellular senescence and the skeleton: pathophysiology and therapeutic implications
por: Khosla, Sundeep, et al.
Publicado: (2022)

Modest Effects of Osteoclast‐Specific ERα Deletion after Skeletal Maturity
por: Doolittle, Madison L., et al.
Publicado: (2023)

In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers
por: Samakkarnthai, Parinya, et al.
Publicado: (2023)

Single‐Cell Integration of BMD GWAS Results Prioritize Candidate Genes Influencing Age‐Related Bone Loss
por: Doolittle, Madison L., et al.
Publicado: (2023)

Local senolysis in aged mice only partially replicates the benefits of systemic senolysis
por: Farr, Joshua N., et al.
Publicado: (2023)

Senescence and Senolytics: State of the Art on Cellular Senescence, Senolytics, and Healthspan
por: Campisi, Judith
Publicado: (2020)

Periodontal Disease and Senescent Cells: New Players for an Old Oral Health Problem?
por: Aquino-Martinez, Ruben, et al.
Publicado: (2020)

The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
por: Zhu, Yi, et al.
Publicado: (2015)

A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues
por: Saul, Dominik, et al.
Publicado: (2022)

Targeting anxiety and senescence with senolytics
por: Raffaele, Marco, et al.
Publicado: (2022)

Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics
por: Gao, Yueyue, et al.
Publicado: (2023)

Targeted clearance of p21‐ but not p16‐positive senescent cells prevents radiation‐induced osteoporosis and increased marrow adiposity
por: Chandra, Abhishek, et al.
Publicado: (2022)

Senolytic CAR T cells reverse senescence-associated pathologies
por: Amor, Corina, et al.
Publicado: (2020)

Aging, Senescent Cells, and Senolytic Drugs: The Path to Translation
por: Kirkland, James
Publicado: (2020)

Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls
por: Owens, W Andrew, et al.
Publicado: (2021)

Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs
por: Kudlova, Natalie, et al.
Publicado: (2022)

From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs
por: L'Hôte, Valentin, et al.
Publicado: (2022)

Senolytics (DQ) Mitigates Radiation Ulcers by Removing Senescent Cells
por: Wang, Huilan, et al.
Publicado: (2020)

First evidence that senolytics are effective at decreasing senescent cells in humans
por: Ellison-Hughes, Georgina M.
Publicado: (2020)

Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development
por: Hu, Li, et al.
Publicado: (2022)

Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration
por: Wu, Yuhao, et al.
Publicado: (2022)

Senolytics Improve Physical Function and Increase Lifespan in Old Age
por: Xu, Ming, et al.
Publicado: (2018)

Senolytics: A Translational Bridge Between Cellular Senescence and Organismal Aging
por: Thoppil, Harikrishnan, et al.
Publicado: (2020)

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
por: Miller, Sean J., et al.
Publicado: (2022)

Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics
por: Beltzig, Lea, et al.
Publicado: (2022)

Senescence‐induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics
por: Lorenzo, Erica C., et al.
Publicado: (2021)

Senolytic effects of quercetin in an in vitro model of pre-adipocytes and adipocytes induced senescence
por: Zoico, Elena, et al.
Publicado: (2021)

Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Senolytics reduce coronavirus-related mortality in old mice
por: Camell, Christina D., et al.
Publicado: (2021)

Augmentation of Bone Regeneration by Depletion of Stress-Induced Senescent Cells Using Catechin and Senolytics
por: Honda, Yoshitomo, et al.
Publicado: (2020)

Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials
por: Franzin, Rossana, et al.
Publicado: (2021)

Identification of Senescent Cells in Peri-Implantitis and Prevention of Mini-Implant Loss Using Senolytics
por: Yang, Niuxin, et al.
Publicado: (2023)

A p21‐GFP zebrafish model of senescence for rapid testing of senolytics in vivo
por: Morsli, Samir, et al.
Publicado: (2023)

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
por: Hickson, LaTonya J., et al.
Publicado: (2019)

Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD
por: Raman, Deepika, et al.
Publicado: (2023)

Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
por: Zhu, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4knfl8obr0sehk4a5k2ajkp4ep